NeuroKaire (formerly Genetika+)

NeuroKaire (formerly Genetika+) is attending the 20th Anniversary Neuroscience Education Institute Congress in Colorado Springs! Join us at Booth 909 from November 7-10 to learn more about our precision psychiatry solutions and how they’re transforming mental health care. We look forward to connecting with professionals dedicated to advancing the field. #NEICongress #PrecisionPsychiatry #MentalHealthInnovation #NeuroKaire

Election got you stressed? You are not alone! We have five ways to help you manage election stress: 1. Limit News Intake 2. Engage in Self-Care 3. Seek Support 4. Stay Informed, Not Overwhelmed 5. Find the Best Solution for You Read the full blog through the link in the comments. #NeuroKaire #Elections2024 #PersonalizedHealth #PrecisionMedicine

Join us at Psych Congress on October 31st as our Co-founder and CSO, Dr. Daphna Laifenfeld, presents our poster: “Guiding Antidepressant Choice by Applying Deep Learning on Patient-Derived Neurons: A Window to Drug Efficacy in Each Patient” https://lnkd.in/e7nPfcTF Visit us at booth #1040 or schedule a time to meet directly: https://lnkd.in/dGUsfsgr #PsychCongress2024 #NeuroKaire #PrecisionPsychiatry #MentalHealthInnovation

NeuroKaire (formerly Genetika+) is honored to be named a finalist for the Fierce Life Sciences Innovation Awards! This recognition highlights our commitment to advancing mental health care through innovative solutions in precision psychiatry. We look forward to the awards announcement on December 2nd! Check out the full list of finalists: https://shorturl.at/yBecz Stay tuned for more updates! #LifeSciences #MentalHealthInnovation #PrecisionPsychiatry #Healthcare #FierceInnovationAwards #FierceLifeSciences #NeuroKaire

We’re attending the 2024 Psych Congress from Oct 29 - Nov 2 in Boston! Visit us at Booth #1040 to learn more about our innovative blood test that helps match patients to the right antidepressant. Want to schedule a meeting? Send us a message, and we’ll be happy to connect! Hope to see you there! #PsychCongress2024 #PrecisionPsychiatry #NeuroKaire #MentalHealthInnovation

Today is World Mental Health Day—a reminder that mental health is just as important as physical health. At NeuroKaire (formerly Genetika+), we’re committed to advancing mental health care through innovation, ensuring everyone gets the support they deserve. Let’s continue to prioritize mental well-being, raise awareness, and break the stigma surrounding mental health. #WorldMentalHealthDay #MentalHealthMatters #BreakTheStigma #NeuroKaire #MentalHealthInnovation #PrecisionMedicine

We are grateful for our friends at Choose New Jersey, Inc. for sharing this exciting news! This major milestone brings us one step closer to advancing precision psychiatry and neurology, starting with our comprehensive pharmacogenetic test. Stay tuned for our official announcement coming soon! #PrecisionMedicine #NeuroKaire #CLIA #MentalHealthInnovation

NeuroKaire (formerly Genetika+) is honored to be selected as one of the 45 startups joining the prestigious initiative led by the The Peres Center for Peace and Innovation. This incredible opportunity underscores our commitment to driving positive change through innovation, alongside some of Israel’s most impactful companies. This year’s cohort is a testament to tech resilience in light of recent challenges, showcasing how innovation can rebuild, inspire, and shape a brighter future. Come experience the Israeli Innovation Expo at the Peres Center, and witness how our innovations, alongside others selected with the Israeli Innovation Authority, are shaping the future! The Peres Center for Peace and Innovation Israel Innovation Authority רשות החדשנות #NeuroKaire #Innovation #Israel #Resilience #Entrepreneurship #TechLeadership #InnovationEcosystem #PrecisionPsychiatry #MentalHealthInnovation #InnovationDreamTeam #PeresCenter #StrongerTogether

Next week, our CEO, Dr. Talia Cohen Solal, will be attending the Neuropsychiatric Drug Development Summit in Boston! This event is a fantastic opportunity to engage with thought leaders in the neuropsychiatric space, and we are grateful to participate in discussions that shape the future of drug development. If you’re attending, let’s connect to discuss NeuroKaire (formerly Genetika+)’s latest innovations and potential collaborations. Reach out to schedule a meeting! #NeuroKaire #NeuropsychiatricDrugDevelopment #MentalHealthInnovation #PrecisionMedicine #Boston

We are thrilled to announce that Issar Yazbin has joined NeuroKaire (formerly Genetika+) as Chief Product Officer! With over 15 years of healthcare product management experience, Issar will help drive our mission to deliver best in class precision medicine solutions in psychiatry and neurology.